Association of Cystatin C with Metabolic Syndrome and Its Prognostic Performance in Non-ST-Segment Elevation Acute Coronary Syndrome with Preserved Renal Function

Figure 2

Kaplan-Meier curves for survival analysis of MACE-free (a, e); cumulative hazard curves for cardiac death (b, f), TVR (c), and heart failure (d). Significant differences between groups were assessed by the log-rank test. MACE: major adverse cardiovascular events; TVR: target vessel revascularization.

(a)

(b)

(c)

(d)

(e)

(f)